Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process.

نویسندگان

  • Cathy Bennett
  • Nimish Vakil
  • Jacques Bergman
  • Rebecca Harrison
  • Robert Odze
  • Michael Vieth
  • Scott Sanders
  • Laura Gay
  • Oliver Pech
  • Gaius Longcroft-Wheaton
  • Yvonne Romero
  • John Inadomi
  • Jan Tack
  • Douglas A Corley
  • Hendrik Manner
  • Susi Green
  • David Al Dulaimi
  • Haythem Ali
  • Bill Allum
  • Mark Anderson
  • Howard Curtis
  • Gary Falk
  • M Brian Fennerty
  • Grant Fullarton
  • Kausilia Krishnadath
  • Stephen J Meltzer
  • David Armstrong
  • Robert Ganz
  • Gianpaolo Cengia
  • James J Going
  • John Goldblum
  • Charles Gordon
  • Heike Grabsch
  • Chris Haigh
  • Michio Hongo
  • David Johnston
  • Ricky Forbes-Young
  • Elaine Kay
  • Philip Kaye
  • Toni Lerut
  • Laurence B Lovat
  • Lars Lundell
  • Philip Mairs
  • Tadakuza Shimoda
  • Stuart Spechler
  • Stephen Sontag
  • Peter Malfertheiner
  • Iain Murray
  • Manoj Nanji
  • David Poller
  • Krish Ragunath
  • Jaroslaw Regula
  • Renzo Cestari
  • Neil Shepherd
  • Rajvinder Singh
  • Hubert J Stein
  • Nicholas J Talley
  • Jean-Paul Galmiche
  • Tony C K Tham
  • Peter Watson
  • Lisa Yerian
  • Massimo Rugge
  • Thomas W Rice
  • John Hart
  • Stuart Gittens
  • David Hewin
  • Juergen Hochberger
  • Peter Kahrilas
  • Sean Preston
  • Richard Sampliner
  • Prateek Sharma
  • Robert Stuart
  • Kenneth Wang
  • Irving Waxman
  • Chris Abley
  • Duncan Loft
  • Ian Penman
  • Nicholas J Shaheen
  • Amitabh Chak
  • Gareth Davies
  • Lorna Dunn
  • Yngve Falck-Ytter
  • John Decaestecker
  • Pradeep Bhandari
  • Christian Ell
  • S Michael Griffin
  • Stephen Attwood
  • Hugh Barr
  • John Allen
  • Mark K Ferguson
  • Paul Moayyedi
  • Janusz A Z Jankowski
چکیده

BACKGROUND & AIMS Esophageal adenocarcinoma (EA) is increasingly common among patients with Barrett's esophagus (BE). We aimed to provide consensus recommendations based on the medical literature that clinicians could use to manage patients with BE and low-grade dysplasia, high-grade dysplasia (HGD), or early-stage EA. METHODS We performed an international, multidisciplinary, systematic, evidence-based review of different management strategies for patients with BE and dysplasia or early-stage EA. We used a Delphi process to develop consensus statements. The results of literature searches were screened using a unique, interactive, Web-based data-sifting platform; we used 11,904 papers to inform the choice of statements selected. An a priori threshold of 80% agreement was used to establish consensus for each statement. RESULTS Eighty-one of the 91 statements achieved consensus despite generally low quality of evidence, including 8 clinical statements: (1) specimens from endoscopic resection are better than biopsies for staging lesions, (2) it is important to carefully map the size of the dysplastic areas, (3) patients that receive ablative or surgical therapy require endoscopic follow-up, (4) high-resolution endoscopy is necessary for accurate diagnosis, (5) endoscopic therapy for HGD is preferred to surveillance, (6) endoscopic therapy for HGD is preferred to surgery, (7) the combination of endoscopic resection and radiofrequency ablation is the most effective therapy, and (8) after endoscopic removal of lesions from patients with HGD, all areas of BE should be ablated. CONCLUSIONS We developed a data-sifting platform and used the Delphi process to create evidence-based consensus statements for the management of patients with BE and early-stage EA. This approach identified important clinical features of the diseases and areas for future studies.

برای دانلود رایگان متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید

ثبت نام

اگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید

منابع مشابه

Canadian Consensus Conference on the management of gastroesophageal reflux disease in adults - update 2004.

BACKGROUND Gastroesophageal reflux disease (GERD) is the most prevalent acid-related disorder in Canada and is associated with significant impairment of health-related quality of life. Since the last Canadian Consensus Conference in 1996, GERD management has evolved substantially. OBJECTIVE To develop up-to-date evidence-based recommendations relevant to the needs of Canadian health care prov...

متن کامل

DNA methylation as an adjunct to histopathology to detect prevalent, inconspicuous dysplasia and early-stage neoplasia in Barrett's esophagus.

PURPOSE Endoscopic surveillance of Barrett's esophagus is problematic because dysplasia/early-stage neoplasia is frequently invisible and likely to be missed because of sampling bias. Molecular abnormalities may be more diffuse than dysplasia. The aim was therefore to test whether DNA methylation, especially on imprinted and X-chromosome genes, is able to detect dysplasia/early-stage neoplasia....

متن کامل

[Barrett's esophagus and esophageal adenocarcinoma].

Barrett's esophagus is a condition in which the normal stratified squamous epithelium is replaced by a specialized metaplastic columnar epithelium. It develops as a consequence of chronic gastroesophageal reflux and predisposes to the development of esophageal adenocarcinoma. Adenocarcinoma develops in Barrett's esophagus by a multistep process in which specialized metaplasia progresses to dysp...

متن کامل

Barrett’s esophagus: Incidence, etiology, pathophysiology, prevention and treatment

Barrett's esophagus is a metaplastic alteration of the normal esophageal epithelium that is detected on endoscopic examination and pathologically confirmed by the presence of intestinal metaplasia on biopsy. Its major significance is as a predisposing factor for esophageal adenocarcinoma, which carries a high mortality rate and a rapidly growing incidence in the United States. Detection of Barr...

متن کامل

Impact of endoscopic biopsy surveillance of Barrett's oesophagus on pathological stage and clinical outcome of Barrett's carcinoma.

BACKGROUND The efficacy of endoscopic biopsy surveillance of Barrett's oesophagus in reducing mortality from oesophageal cancer has not been confirmed. AIMS To investigate the impact of endoscopic biopsy surveillance on pathological stage and clinical outcome of Barrett's carcinoma. METHODS A clinicopathological comparison was made between patients who initially presented with oesophageal a...

متن کامل

ذخیره در منابع من


  با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید

عنوان ژورنال:
  • Gastroenterology

دوره 143 2  شماره 

صفحات  -

تاریخ انتشار 2012